North County Neurology Associates

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials
• Obstructive sleep apnoea1 trial
• Postural tachycardia syndrome (POTS)1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed3 trials
• Terminated2 trials
• Active, not recruiting1 trial

Lead sponsor

• Cassava Sciences, Inc.2 trials
• Eli Lilly and Company2 trials
• Apnimed1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06593600· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

  NCT05813275· Phase 3· Apnimed· Source

• Terminated

  Open-label Extension for Phase 3 Clinical Trials of Simufilam

  NCT05575076· Phase 3· Cassava Sciences, Inc.· Source

• Completed

  A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

  NCT05463731· Phase 3· Eli Lilly and Company· Source

• Terminated

  Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT05026177· Phase 3· Cassava Sciences, Inc.· Source